BCWORLD PHARM. Co. Ltd (200780) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.43 Billion ≈ $968.52K USD) by net assets (₩72.50 Billion ≈ $49.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 200780 stock market capitalisation for the company's overall valuation and market capitalisation.

BCWORLD PHARM. Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how BCWORLD PHARM. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BCWORLD PHARM. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their cash flow conversion efficiency. Explore 200780 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Puma Exploration Inc V:PUMA	-0.007x
Les Enphants Co Ltd TW:2911	-0.426x
Glostrext Berhad KLSE:0284	0.044x
Mohenz.Co.Ltd KQ:006920	0.017x
TRC Construction Public Company Limited BK:TRC	0.069x
Grande Group Limited Class A Ordinary Shares NASDAQ:GRAN	0.028x
TPC Plus Bhd KLSE:7176	-0.173x
First Hydrogen Corp V:FHYD	0.122x

Annual Cash Flow Conversion Efficiency for BCWORLD PHARM. Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of BCWORLD PHARM. Co. Ltd from 2015 to 2024. View BCWORLD PHARM. Co. Ltd (200780) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩76.67 Billion ≈ $51.96 Million	₩4.04 Billion ≈ $2.74 Million	0.053x	-60.64%
2023-12-31	₩81.64 Billion ≈ $55.33 Million	₩10.94 Billion ≈ $7.41 Million	0.134x	+54.84%
2022-12-31	₩79.55 Billion ≈ $53.91 Million	₩6.88 Billion ≈ $4.66 Million	0.087x	+1237.07%
2021-12-31	₩81.46 Billion ≈ $55.20 Million	₩-619.83 Million ≈ $-420.05K	-0.008x	+85.94%
2020-12-31	₩101.69 Billion ≈ $68.92 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.054x	-143.45%
2019-12-31	₩97.24 Billion ≈ $65.90 Million	₩12.11 Billion ≈ $8.21 Million	0.125x	+110.10%
2018-12-31	₩90.09 Billion ≈ $61.05 Million	₩5.34 Billion ≈ $3.62 Million	0.059x	-39.05%
2017-12-31	₩81.23 Billion ≈ $55.05 Million	₩7.90 Billion ≈ $5.35 Million	0.097x	+2848.61%
2016-12-31	₩73.88 Billion ≈ $50.06 Million	₩243.66 Million ≈ $165.13K	0.003x	-97.47%
2015-12-31	₩67.40 Billion ≈ $45.68 Million	₩8.78 Billion ≈ $5.95 Million	0.130x	--

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$20.92 Million

₩30.88 Billion KRW

Market Cap Rank

#25053 Global

#1827 in Korea

Share Price

₩3020.00

Change (1 day)

-0.33%

52-Week Range

₩2960.00 - ₩5870.00

All Time High

₩30700.49